A selection of experts from Asahi Kasei Bioprocess discuss the key practices behind successful processes.

Understanding how choices in chromatography solutions impact overall process efficiency.

Personalized medicine, digital therapeutics, and GLP-1s; experts tell us what areas are hot in pharma’s future.

We find out why Cas12l incorporated into a gene-writing system could help advance the field of gene editing.

Unethical practices and forced labor exist in HPMC supply chains. Here’s what can be done about it.

Pharma companies are well accustomed to supply chain issues, but how prepared are they for issues impacting access to medical devices?

The essential roles of optimized cell lines and vectors in accelerating bioprocessing.

Clinical trials can be needlessly complex – which impacts the bottom line of trial sponsors. It’s time for change.

Celebrate a decade of pharma innovation with The Medicine Maker’s top features, from cancer vaccines to CRISPR breakthroughs.

Consider CIRM as a bank. We don’t conduct research ourselves: we fund it – and have become the largest dedicated funder of stem cell and gene therapy